{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:49:43Z","timestamp":1764510583699,"version":"3.46.0"},"reference-count":24,"publisher":"Practical Medicine Publishing House","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Background.\u00a0The most common diseases among cutaneous T-cell lymphomas are mycosis fungoides (MF) and its leukemic variant Sezary Syndrome (SS). These malignant tumors have a progressive character course. To date, no therapy for these diseases has proven effective, especially in the late stages of the disease.\r\nAim.\u00a0We aimed to assess the effectiveness of treating resistant forms of MF\/SS with prolonged gemcitabine regimen after initial treatment failure.\r\nMaterials &amp; Methods.\u00a0The study included 14 patients with drug-resistant forms of MF\/SS (10 patients with MF, 3 patients with SS, and 1 patient with the transformation of MF into large cell lymphoma). The median age was 62 years (range 34\u201378 years). The study population included 9 males and 7 females. Gemcitabine was administered at a dosage of 250 mg\/m2\u00a0as a 6\u20138 hour IV infusion weekly, in a cycle of 21\u201328 days.\r\nResults.\u00a0The overall response was 79\u00a0% (29\u00a0% of patients with complete remission, 50\u00a0% of patients with partial remission). In 21\u00a0% of patients, the treatment results met the criteria for tumor stabilization. The disease progression was observed in 2 (14\u00a0%) patients. This study demonstrates the potential of using prolonged gemcitabine regimen in patients of different age groups with advanced resistant MF\/SS who received at least two courses of previous ineffective therapy. In order to evaluate long-term results, further research is needed.\r\nConclusion.\u00a0The administration of prolonged gemcitabine regimen may be a treatment of choice in resistant forms of MF\/SS after initial treatment failure in different age groups including elderly patients.<\/jats:p>","DOI":"10.21320\/2500-2139-2017-10-3-366-371","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T07:15:28Z","timestamp":1500707728000},"page":"366-371","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome","\u041b\u0435\u0447\u0435\u043d\u0438\u0435 \u0440\u0435\u0437\u0438\u0441\u0442\u0435\u043d\u0442\u043d\u044b\u0445 \u0444\u043e\u0440\u043c \u0433\u0440\u0438\u0431\u043e\u0432\u0438\u0434\u043d\u043e\u0433\u043e \u043c\u0438\u043a\u043e\u0437\u0430 \u0438 \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u0430 \u0421\u0435\u0437\u0430\u0440\u0438"],"prefix":"10.21320","volume":"10","author":[{"given":"Liliya Gamilevna","family":"Gorenkova","sequence":"first","affiliation":[{"name":"Hematology Research Center, 4\u0430 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4\u0430, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Penskaya","sequence":"additional","affiliation":[{"name":"Hematology Research Center, 4\u0430 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4\u0430, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Kravchenko","sequence":"additional","affiliation":[{"name":"Hematology Research Center, 4\u0430 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4\u0430, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Kovrigina","sequence":"additional","affiliation":[{"name":"Hematology Research Center, 4\u0430 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4\u0430, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. N.","family":"Moiseeva","sequence":"additional","affiliation":[{"name":"Hematology Research Center, 4\u0430 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4\u0430, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. I.","family":"Vorob\u2019ev","sequence":"additional","affiliation":[{"name":"Hematology Research Center, 4\u0430 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4\u0430, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"15691","unstructured":"\u0412\u0438\u043d\u043e\u0433\u0440\u0430\u0434\u043e\u0432\u0430 \u042e.\u0415., \u041f\u043e\u0442\u0435\u043a\u0430\u0435\u0432 \u041d.\u0421., \u0412\u0438\u043d\u043e\u0433\u0440\u0430\u0434\u043e\u0432 \u0414.\u041b. \u041b\u0438\u043c\u0444\u043e\u043c\u044b \u043a\u043e\u0436\u0438: \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u0435. \u041c.: \u041f\u0440\u0430\u043a\u0442\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0430, 2014. 176 \u0441."},{"key":"15692","unstructured":"[Vinogradova YuE, Potekaev NS, Vinogradov DL. Limfomy kozhi: diagnostika i lechenie. (Skin lymphomas: diagnosis and treatment.) Moscow: Prakticheskaya meditsina Publ.; 2014. 176 p. (In Russ)]"},{"key":"15693","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"15694","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2003.01643.x"},{"key":"15695","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01591-3"},{"key":"15696","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11593"},{"key":"15697","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2006.00083.x"},{"key":"15698","doi-asserted-by":"publisher","DOI":"10.2340\/0001555560542544"},{"key":"15699","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.449"},{"key":"15700","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.10.014"},{"key":"15701","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2603"},{"key":"15702","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21449"},{"key":"15703","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2006.n.039"},{"key":"15704","doi-asserted-by":"publisher","DOI":"10.1179\/1973947813Y.0000000139"},{"key":"15705","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005817024382"},{"key":"15706","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200110000-00001"},{"key":"15707","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199907000-00003"},{"key":"15708","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-5-61"},{"key":"15709","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120023767"},{"key":"15710","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199908000-00001"},{"key":"15711","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006478702342"},{"key":"15712","unstructured":"\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u043f\u043e \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0435 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u044e \u043b\u0438\u043c\u0444\u043e\u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0418.\u0412. \u041f\u043e\u0434\u0434\u0443\u0431\u043d\u043e\u0439, \u0412.\u0413. \u0421\u0430\u0432\u0447\u0435\u043d\u043a\u043e. \u041c.: \u0411\u0443\u043a\u0438 \u0412\u0435\u0434\u0438, 2016. \u0421. 85\u201391."},{"key":"15713","unstructured":"[Poddubnaya IV, Savchenko VG, eds. Rossiiskie klinicheskie rekomendatsii po diagnostike i lecheniyu limfoproliferativnykh zabolevanii. (Russian clinical guidelines in diagnosis and treatment of lymphoproliferative disorders). Moscow: Buki Vedi Publ.; 2016. pp. 85\u201391. (In Russ)]"},{"key":"15714","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-142653"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/439\/407","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/439\/407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:31:19Z","timestamp":1764502279000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2017-10-3-366-371","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"type":"electronic","value":"2500-2139"},{"type":"print","value":"1997-6933"}],"subject":[],"published":{"date-parts":[[2017,7,1]]}}}